ALDVI.PA
Advicenne SA
Price:  
0.65 
EUR
Volume:  
11,711.00
France | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ALDVI.PA EV/EBITDA

-424.1%
Upside

As of 2026-11-12, the EV/EBITDA ratio of Advicenne SA (ALDVI.PA) is -16.35. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ALDVI.PA's latest enterprise value is 27.21 mil EUR. ALDVI.PA's TTM EBITDA according to its financial statements is -1.66 mil EUR. Dividing these 2 quantities gives us the above ALDVI.PA EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 6.6x - 7.0x 6.8x
Forward P/E multiples 8.1x - 10.3x 9.2x
Fair Price (2.13) - (2.01) (2.12)
Upside -425.8% - -406.7% -424.1%
0.65 EUR
Stock Price
(2.12) EUR
Fair Price

ALDVI.PA EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2026-11-10 -16.35
2026-11-09 -16.23
2026-11-06 -16.14
2026-11-05 -16.16
2026-11-04 -16.14
2026-11-03 -16.39
2026-11-02 -16.28
2026-10-30 -16.29
2026-10-29 -16.67
2026-10-28 -16.52
2026-10-27 -16.25
2026-10-26 -16.14
2026-10-23 -16.16
2026-10-22 -16.14
2026-10-21 -16.23
2026-10-20 -16.23
2026-10-19 -16.32
2026-10-16 -16.32
2026-10-15 -16.32
2026-10-14 -16.23
2026-10-13 -16.53
2026-10-12 -16.84
2026-10-09 -16.40
2026-10-08 -16.05
2026-10-07 -16.05
2026-10-06 -16.06
2026-10-05 -16.19
2026-10-02 -16.62
2026-10-01 -16.49
2026-09-30 -16.84
2026-09-29 -16.90
2026-09-28 -16.89
2026-09-25 -16.94
2026-09-24 -17.21
2026-09-23 -17.20
2026-09-22 -17.41
2026-09-21 -17.55
2026-09-18 -18.21
2026-09-17 -17.29
2026-09-16 -16.68
2026-09-15 -17.12
2026-09-14 -18.07
2026-09-11 -18.21
2026-09-10 -18.36
2026-09-09 -18.51
2026-09-08 -18.75
2026-09-07 -18.78
2026-09-04 -19.13
2026-09-03 -19.08
2026-09-02 -18.64